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Objective
To compare serum and urine reactive nitrogen intermedi-
ates (RNI) and citrulline levels in children with Henoch-
Schonlein Purpura (HSP) during activity and remission.
Methods
The study group consisted of 14 children with biopsy
proven HSP. We measured serum and urine RNI and cit-
rulline levels by spectrophotometry in the active phase
and after remission.
Results
Serum RNI levels were 303.95 ± 221.44 nmol/ml in chil-
dren with active HSP and 72.57 ± 26.56 nmol/ml during
remission, the differences being statistically significant (p
= 0.002). Mean urine RNI levels in children with active
HSP were significantly higher than that seen during remis-
sion (3.25 ± 1.80 vs. 1.68 ± 0.65 nmol/ml; p = 0.003).
Similarly, serum citrulline levels during disease activity
were 790.65 ± 707.87 nmol/ml as compared to 281.49 ±
307.29 nmol/ml at the time of remission, the differences
being statistically significant (p = 0.002). Mean urine cit-
rulline levels in children with active disease was 1969.94
± 1655.42 nmol/ml as compared to 1099.34 ± 955.82
nmol/ml in children with remission, (p = 0.007).
Conclusion
Serum and urine RNI and citrulline levels were signifi-
cantly higher during the active phase of HSP. These find-
ings suggest that nitric oxide may perhaps have a role in
the pathogenesis of HSP. Further, these laboratory param-
eters could be of value in monitoring disease activity.
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